Aortoesophageal and aortobronchial fistula caused by Candida albicans after thoracic endovascular aortic repair
Abstract
Introduction. Endovascular stent-graft placement has emerged as a minimally invasive alternative to open surgery for the treatment of aortic aneurysms and dissections. There are few reports on stent graft infections and aortoenteric fistula after endovascular thoracic aortic aneurysm repair, and the first multicentric study (Italian survey) showed the incidence of about 2%. Case report. We presented a 69-year-old male patient admitted to our hospital 9 months after thoracic endovascular aortic repair, due to severe chest pain in the left hemithorax and arm refractory to analgesic therapy. Multislice computed tomography (MSCT) showed a collection between the stent graft and the esophagus with thin layers of gas while gastroendoscopy showed visible blood jet 28 cm from incisive teeth. Surgical treatment was performed in collaboration of two teams (esophageal and vascular surgical team). After explantation of the stent graft and in situ reconstruction by using Dacron graft subsequent esophagectomy and graft omentoplasty were made. After almost four weeks patient developed hemoptisia as a sign of aortobronchial fistula. Treatment with implantation of another aortic cuff of 26 mm was performed. The patient was discharged to the regional center with negative blood culture, normal inflammatory parameters and respiratory function. Three months later the patient suffered deterioration with the severe weight loss and pneumonia caused by Candida albicans and unfortunately died. The survival time from the surgical treatment of aortoesophageal fistula was 4 months. Conclusion. Even if endovascular repair of thoracic aortic diseases improves early results, risk of infection should not be forgotten. Postoperative respiratory deterioration and finally hemoptisia could be the symptoms of another fistula.
References
Iezzi R, Cotroneo AR, Marano R, Filippone A, Storto ML. Endo-vascular treatment of thoracic aortic diseases: Follow-up and complications with multi-detector computed tomography an-giography. Eur J Radiol 2008; 65(3): 365−76.
Dake MD, Miller DC, Semba CP, Mitchell RS, Walker PJ, Liddell RP. Transluminal placement of endovascular stent-grafts for the treatment of descending thoracic aortic aneurysms. N Engl J Med 1994; 331(26): 1729−34.
Chiesa R, Tshomba Y, Kahlberg A, Marone EM, Civilini E, Coppi G, et al. Menagment of thoracic endograf infection. J Cardiovasc Surg (Torino) 2010; 51(1): 15−31.
Hance KA, Hsu J, Eskew T, Hermreck AS. Secondary aor-toesophageal fistula after endoluminal exclusion because of thoracic aortic transection. J Vasc Surg 2003; 37(4): 886−8.
Parson RE, Sanchez LA, Marin ML, Holbrook KA, Faries PI, Suggs WD, et al. Comparison of endovascular and conventional vascular prosthesis in an experimental infection model. J Vasc Surg 1996; 24(6): 920−6; discussion 925–6.
Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg 1999; 67(6): 1990−3.
Eggebrecht H, Baumgart D, Radecke K, von Birgelen C, Treichel U, Herold U, et al. Aortoesophagela fistula secondary to stent graft repair of the thoracic aorta. J Endovasc Therapy 2004; 11(2): 161−7.
Sternberg WC 3rd, Money SR, Greenberg RK, Chuter TA; Zenith Investigators . Influence of endograft oversizing on device mi-gration, endoleak, aneurysm shrinkage, and aortic neck dilata-tion: Results from the Zenith Multicenter Trial. J Vasc Surg 2004; 39(1): 20−6.
